Home » Topics » BioWorld Science

BioWorld Science
RSS

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

BMS-191095 in phase I for ischemia

April 26, 1996

Kanebo reveals new Na+/Ca2+ exchange inhibitor

April 26, 1996

FR-168888 shows myocardial protective effects in animals

April 26, 1996

Banyu's BR-1022 for angina

April 26, 1996

CP-060S suppresses myocardial cell calcium overload

April 26, 1996

Novel vasodilator MCC-134 reported by Mitsubishi Chemical

April 26, 1996

PC-286 lowers blood pressure in rats

April 26, 1996

Z-6568 in development at Zambon for cardiovascular disorders

April 26, 1996

Tanabe Seiyaku investigates ET antagonists

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...